These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15279129)

  • 1. Evaluation of the substance abuse and crime prevention act: treatment clients and program types during the first year of implementation.
    Evans E; Longshore D
    J Psychoactive Drugs; 2004 May; Suppl 2():165-74. PubMed ID: 15279129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Substance Abuse and Crime Prevention Act: client characteristics, treatment completion and re-offending three years after implementation.
    Evans E; Longshore D; Prendergast M; Urada D
    J Psychoactive Drugs; 2006 Nov; Suppl 3():357-67. PubMed ID: 17357527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When you assume...the reality of implementing a legally mandated substance abuse treatment program.
    Wiley D; Beattie M; Nguyen H; Puckett K; Banerjee K; Poon W
    J Psychoactive Drugs; 2004 May; Suppl 2():175-80. PubMed ID: 15279130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Offender diversion into substance use disorder treatment: the economic impact of California's proposition 36.
    Anglin MD; Nosyk B; Jaffe A; Urada D; Evans E
    Am J Public Health; 2013 Jun; 103(6):1096-102. PubMed ID: 23597352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug treatment program compliance and resistance activities during implementation of California's Proposition 36.
    Reynolds G
    J Health Hum Serv Adm; 2009; 32(1):85-106. PubMed ID: 19558034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Criminal justice itreatment admissions for methamphetamine use in California: a focus on Proposition 36.
    Anglin MD; Urada D; Brecht ML; Hawken A; Rawson R; Longshore D
    J Psychoactive Drugs; 2007 Nov; Suppl 4():367-81. PubMed ID: 18284103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of perceived coercion and motivation on treatment completion and re-arrest among substance-abusing offenders.
    Prendergast M; Greenwell L; Farabee D; Hser YI
    J Behav Health Serv Res; 2009 Apr; 36(2):159-76. PubMed ID: 18516684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Client and program characteristics associated with wait time to substance abuse treatment entry.
    Andrews CM; Shin HC; Marsh JC; Cao D
    Am J Drug Alcohol Abuse; 2013 Jan; 39(1):61-8. PubMed ID: 22783953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial differences in desistance from substance abuse: the impact of religious involvement on recovery.
    Chu DC; Sung HE
    Int J Offender Ther Comp Criminol; 2009 Dec; 53(6):696-716. PubMed ID: 18647819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of drug treatment programs in reducing criminal behavior: a meta-analysis.
    Holloway KR; Bennett TH; Farrington DP
    Psicothema; 2006 Aug; 18(3):620-9. PubMed ID: 17296096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The costly bonus: cocaine related crime among methadone treatment clients.
    Hunt D; Spunt B; Lipton D; Goldsmith D; Strug D
    Adv Alcohol Subst Abuse; 1986; 6(2):107-22. PubMed ID: 3604786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological interventions for drug-using offenders.
    Perry AE; Neilson M; Martyn-St James M; Glanville JM; McCool R; Duffy S; Godfrey C; Hewitt C
    Cochrane Database Syst Rev; 2013 Dec; (12):CD010862. PubMed ID: 24353217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of community substance abuse treatment services on clients' criminal arrests.
    Ventura LA; Lambert EG
    Addict Behav; 2005 Aug; 30(7):1459-63. PubMed ID: 16022942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harm reduction for drug abusing ex-offenders: outcome of the California prevention and education project MORE project.
    Bowser BP; Jenkins-Barnes T; Dillard-Smith C; Lockett G
    J Evid Based Soc Work; 2010 Jan; 7(1):15-29. PubMed ID: 20178022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Criminal outcomes and costs of treatment services for injecting and non-injecting heroin users: evidence from a national prospective cohort survey.
    Healey A; Knapp M; Marsden J; Gossop M; Stewart D
    J Health Serv Res Policy; 2003 Jul; 8(3):134-41. PubMed ID: 12869338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment entry barriers among California's Proposition 36 offenders.
    Evans E; Li L; Hser YI
    J Subst Abuse Treat; 2008 Dec; 35(4):410-8. PubMed ID: 18514474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mothers in substance abuse treatment: differences in characteristics based on involvement with child welfare services.
    Grella CE; Hser YI; Huang YC
    Child Abuse Negl; 2006 Jan; 30(1):55-73. PubMed ID: 16406024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of benzodiazepine use on methadone maintenance treatment outcomes.
    Brands B; Blake J; Marsh DC; Sproule B; Jeyapalan R; Li S
    J Addict Dis; 2008; 27(3):37-48. PubMed ID: 18956528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment illegal activities of a nationwide sample of adolescent substance abuse clients.
    Kinlock TW; Gordon MS; Battjes RJ
    J Psychoactive Drugs; 2004 Mar; 36(1):5-12. PubMed ID: 15152705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reductions in criminal convictions after addiction treatment: 5-year follow-up.
    Gossop M; Trakada K; Stewart D; Witton J
    Drug Alcohol Depend; 2005 Sep; 79(3):295-302. PubMed ID: 16102373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.